ABIOMED Inc. (NASDAQ: ABMD) stock closed at 281.71 per share at the end of the most recent trading day (a -4.11% change compared to the prior day closing price) with a volume of 209.35K shares and market capitalization of 12.81B. Is a component of S&P 500, Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 1725 people. ABIOMED Inc. CEO is Michael R. Minogue.

The one-year performance of ABIOMED Inc. stock is -15.25%, while year-to-date (YTD) performance is -21.57%. ABMD stock has a five-year performance of 87.79%. Its 52-week range is between 219.845 and 379.295, which gives ABMD stock a 52-week price range ratio of 38.80%

ABIOMED Inc. currently has a PE ratio of 90.30, a price-to-book (PB) ratio of 8.14, a price-to-sale (PS) ratio of 15.40, a price to cashflow ratio of 43.10, a PEG ratio of 2.32, a ROA of 8.85%, a ROC of 7.12% and a ROE of 9.90%. The company’s profit margin is 20.26%, its EBITDA margin is 27.60%, and its revenue ttm is $779.17 Million , which makes it $17.08 revenue per share.

Of the last four earnings reports from ABIOMED Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $1.09 for the next earnings report. ABIOMED Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for ABIOMED Inc. is Moderate Buy (1.78), with a target price of $347, which is +23.18% compared to the current price. The earnings rating for ABIOMED Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

ABIOMED Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

ABIOMED Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 14.68, ATR14 : 9.74, CCI20 : 81.49, Chaikin Money Flow : 0.35, MACD : 9.47, Money Flow Index : 68.69, ROC : 3.15, RSI : 56.38, STOCH (14,3) : 72.63, STOCH RSI : 0.46, UO : 64.84, Williams %R : -27.37), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of ABIOMED Inc. in the last 12-months were: David M. Weber (Option Excercise at a value of $233 279), David M. Weber (Sold 25 825 shares of value $8 288 310 ), Martin P. Sutter (Sold 40 642 shares of value $13 231 148 ), Michael R. Minogue (Option Excercise at a value of $80 840), Michael R. Minogue (Sold 3 492 shares of value $1 222 200 ), Paul G. Thomas (Sold 663 shares of value $219 301 ), Todd A. Trapp (Sold 3 000 shares of value $992 430 )